Swaid Forat, Geller David A
Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, UPMC Liver Cancer Center, University of Pittsburgh Medical Center, 3471 Fifth Avenue, Suite 300, Pittsburgh, PA 15213, USA.
Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, UPMC Liver Cancer Center, University of Pittsburgh Medical Center, 3471 Fifth Avenue, Suite 300, Pittsburgh, PA 15213, USA.
Surg Oncol Clin N Am. 2019 Apr;28(2):215-227. doi: 10.1016/j.soc.2018.11.002. Epub 2019 Feb 2.
Laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) has been rapidly expanding. With increasing experience, the safety and feasibility of LLR for HCC have been demonstrated. LLR of HCC is becoming the standard of care for minor liver resections, and even major LLR are being performed safely in experienced centers. In most reports, patients undergoing LLR had less blood loss, fewer transfusions, less postoperative morbidity, and shorter length of stay compared with open liver resections (OLR). The 5-year overall and disease-free survival rates for patients undergoing LLR for HCC are comparable to OLR.
用于肝细胞癌（HCC）的腹腔镜肝切除术（LLR）一直在迅速发展。随着经验的增加，LLR治疗HCC的安全性和可行性已得到证实。HCC的LLR正成为小范围肝切除术的标准治疗方法，甚至在经验丰富的中心，大型LLR也能安全进行。在大多数报告中，与开放性肝切除术（OLR）相比，接受LLR的患者失血量更少、输血次数更少、术后发病率更低且住院时间更短。接受LLR治疗HCC的患者的5年总生存率和无病生存率与OLR相当。
